
Today’s Yangtze funding roundup: robotics, AI processor, nuclear fusion…
The funding will accelerate commercialization, manufacturing and next-generation technology development.

The funding will accelerate commercialization, manufacturing and next-generation technology development.

Founded in 2025, Gestala is committed to developing ultrasound-based non-invasive BCIs, an alternative to conventional implanted electrical systems.

If Neuracle reaches the STAR Market first, the company could establish the first public-market valuation benchmark for China’s domestic BCI industry.

The management may consider another fundraising round this year before attempting an initial public offering in 2027, as investor interest in brain-computer interface technologies accelerates.

A central focus is the development of brain-computer interfaces (BCIs), particularly in neurorehabilitation. The policy calls for leveraging national AI pilot platforms to accelerate clinical deployment.